Aytu BioPharma (NASDAQ:AYTU) Shares Pass Below Fifty Day Moving Average – Should You Sell?

Aytu BioPharma, Inc. (NASDAQ:AYTU)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.19 and traded as low as $1.00. Aytu BioPharma shares last traded at $1.05, with a volume of 26,958 shares changing hands.

Aytu BioPharma Trading Up 1.9 %

The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.81 and a current ratio of 0.98. The company has a market capitalization of $6.48 million, a price-to-earnings ratio of -0.72 and a beta of 0.07. The firm has a fifty day moving average price of $1.19 and a 200-day moving average price of $1.55.

Aytu BioPharma (NASDAQ:AYTU) last posted its quarterly earnings data on Wednesday, February 12th. The company reported ($0.28) earnings per share for the quarter. Aytu BioPharma had a negative return on equity of 19.30% and a negative net margin of 7.62%.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.